cyclosporine and Nephrosis, Lipoid

cyclosporine has been researched along with Nephrosis, Lipoid in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	23 (24.47)	18.2507
2000's	41 (43.62)	29.6817
2010's	24 (25.53)	24.3611
2020's	6 (6.38)	2.80

Authors

Authors	Studies
Cheng, X; Cui, Z; Liu, G; Meng, L; Wang, F; Wang, X; Zhang, Y; Zhao, C; Zhao, M	1
Aoyagi, J; Betsui, H; Ito, T; Kanai, T; Kurosaki, M; Maru, T; Odaka, J; Saito, T; Yamagata, T	1
Długosz, G; Masajtis-Zagajewska, A; Nowicki, M	1
Furuichi, K; Ishimoto, T; Koizumi, M; Kurita, N; Nakaya, I; Nishiwaki, H; Oe, Y; Okada, H; Sasaki, S; Shimizu, S; Sofue, T; Wada, T	1
Fujinaga, S; Hirano, D; Nakagawa, M; Nishino, T; Umeda, C; Watanabe, Y	1
Asai, R; Kaneko, T; Seki, M; Tsuruoka, S	1
Fujinaga, S; Nishino, T; Urushihara, Y	1
Imai, N; Kimura, K; Matsui, K; Sakurada, T; Shibagaki, Y; Shirai, S; Sueki, S; Tominaga, N; Yasuda, T	1
Fujinaga, S; Shimizu, T	1
Ehara, Y; Fujita, M; Fujiwara, A; Hirawa, N; Kaneda, T; Katsumata, M; Kobayashi, Y; Okuyama, Y; Saka, S; Toya, Y; Umemura, S; Yamamoto, Y; Yasuda, G; Yatsu, K; Yutoh, J	1
Gellermann, J; Querfeld, U; Schaefer, F	1
Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y	1
Freudenberg, F; Helmchen, U; Kemper, MJ; Klaassen, I; Lehnhardt, A; Möller, K; Oh, J; Özgören, B; Sadowski, CE; Timmermann, K; van Husen, M	1
Ekim, M; Fitöz, S; Kurt-Şükür, ED; Özçakar, ZB; Teber, S; Ünal İnce, E; Yalçinkaya, F; Yilmaz, S	1
Hamada, R; Hamasaki, Y; Hataya, H; Honda, M; Inaba, A; Ishikura, K; Kaneko, T; Komaki, F; Mori, M; Sakai, T	1
Bi, Y; Chen, J; Feng, S; Huang, X; Jiang, H; Lan, HY; Li, M; Li, X; Lin, C; Lin, W; Shen, J; Shen, X; Wang, H; Wang, L; Wang, Y; Weng, C; Xie, Z; Ying, M; Zhao, J; Zhou, J; Zhou, Q; Zhu, T	1
Bian, R; Gao, X; Mei, C; Xu, C; Xu, D	1
Dorresteijn, EM; Hop, WC; Kist-van Holthe, JE; Levtchenko, EN; Nauta, J; van der Heijden, AJ	1
Fukuma, Y; Hatae, K; Hisano, S; Iwasaki, H; Kaku, Y; Niimi, K; Saitoh, T; Segawa, Y; Takeshita, M	1
Fukatsu, A; Hayashi, M; Kimura, N	1
Hatta, S; Kimura, K; Konno, Y; Kuboshima, S; Masuhara, K; Sato, T; Shima, Y; Shirai, S; Tsuchida, H; Yasuda, T	1
Eldin, KW; Feig, DI; Hicks, MJ; Swartz, SJ	1
Cho, BS; Hahn, WH; Kim, SD; Park, SS	1
Fujimoto, S; Fukuda, A; Fukudome, K; Hara, S; Iwatsubo, S; Kitamura, K; Komatsu, H; Nishiura, R; Sato, Y; Yamada, K	1
El-Dahshan, K; El-Husseini, A; Sabry, A; Sobh, M	1
Gipson, DS; Greenbaum, LA; Lin, JJ; Mahan, JD; Massengill, SF; Miles, P; Nagaraj, S; Powell, L; Smoyer, WE; Trachtman, H; Wigfall, D; Yao, L	1
Eguchi, A; Nitta, K; Takei, T; Tsuchiya, K; Yoshida, T	1
Fujinaga, S; Hirano, D; Ito, S; Kamei, K; Kaneko, K; Nishizaki, N; Ohtomo, Y; Shimizu, T	1
Micheletti, MV; Pela, I	1
Hirayama, K; Kobayashi, M	1
Shigidi, MM	1
Jeong, HJ; Kim, JH; Kim, PK; Lee, JS; Lim, BJ; Park, SJ; Shin, JI; Yoon, SJ	1
Amemiya, N; Itabashi, M; Kojima, C; Nitta, K; Nokiba, H; Takei, T	1
Endo, A; Fujinaga, S; Hirano, D; Kaneko, K; Ohtomo, Y; Shimizu, T; Watanabe, T	1
Fujinaga, S; Hirano, D; Kaneko, K; Murakami, H; Ohtomo, Y; Shimizu, T	1
Fujita, S; Iharada, A; Kaneko, K; Miyazaki, K; Okada, M; Sakata, N; Sugimoto, K; Takemura, T; Tsuji, S; Yanagida, H	1
Kemper, MJ; Oh, J	1
Ando, Y; Hamano, Y; Inoue, M; Ito, C; Kusano, E; Morishita, Y; Muto, S; Yumura, W	1
Hamasaki, Y; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kaneko, T; Matsuyama, T; Nakanishi, K; Nakazato, H; Sasaki, S; Yoshikawa, N	1
Honda, K; Itabashi, M; Koike, M; Nihei, H; Nitta, K; Suzuki, K; Tsukada, M; Uchida, K; Yumura, W	1
Filler, G	1
Aymanns, C; Helmchen, U; Hüttner, S; Kadlec, N; Keller, F; Lindemann, B; Stracke, S	1
Ho, YW; Tam, MK; Tang, AW; Tang, S	1
Fukuda, S; Hirano, T; Kawamura, T; Kohsaka, S; Oka, K; Yoshida, M; Yoshikawa, N	1
Hong, SW; Jeong, HJ; Kim, PK; Lim, BJ	1
Eto, T; Fujimoto, S; Hara, S; Sakamaki, H; Sato, Y; Yamada, K	1
Honda, M; Ikeda, M; Mori, K	1
Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Okada, T; Takeguchi, F; Tomaru, R	1
Hertzberg, MS; Nankivell, BJ; Stevenson, WS	1
Donia, A; El-Basuony, F; El-Husseini, A; Hassan, N; Mahmoud, I; Sabry, A; Sayed-Ahmad, N; Sheashaa, H; Sobh, M	1
Akashi, M; Hirano, T; Iwahori, T; Nakabayashi, I; Oka, K; Watanabe, T; Yoshida, M; Yoshikawa, N	1
Akashi, S; Fujinaga, S; Kaneko, K; Murakami, H; Ohtomo, Y; Shimizu, T; Takada, M; Yamashiro, Y	1
Davies, K; Holt, S; Tomlinson, L; Wright, DA	1
Biesenbach, G; Raml, A; Schmekal, B; Sedlak, M; Stuby, U; Syre', G	1
Asaka, M; Wada, T; Yamaya, H; Yokoyama, H	1
Appel, G; Busch, J; Crew, RJ; D'Agati, V; Markowitz, G; Stokes, B; Valeri, A; Waldman, M	1
Alexopoulos, E; Cattran, DC; Choukroun, G; Heering, P; Hoyer, PF; Johnston, A; Meyrier, A; Nachman, P; Ponticelli, C; Praga, M; Saito, T; Yoshikawa, N	1
Aggarwal, N; Batwara, R; McCarthy, ET; Savin, VJ; Sharma, M; Sharma, R	1
Büscher, R; Hoyer, PF; Kranz, B; Vester, U; Wingen, AM	1
Arai, H; Kuroume, T; Maruyama, K; Ogawa, T; Seki, Y; Tomizawa, S	1
Kang, CM; Kim, HS; Kim, MJ; Kim, SG; Lee, HY	1
Barratt, TM; Dillon, MJ; Hulton, SA; Neuhaus, TJ	1
Barratt, TM; Dillon, MJ; Hulton, SA; Jadresic, L; Shah, V; Trompeter, RS	1
Habib, R; Niaudet, P	1
Auriche, P; Callard, P; Meyrier, A; Noël, LH	1
Ponticelli, C	2
Alaniz, C; Brosius, FC; Palmieri, J	1
Abu-Farsakh, H; Berry, PL; Hawkins, EP; Hill, LL; Powell, D	1
Clasen, W; Fuhs, M; Ittel, TH; Kindler, J; Mihatsch, MJ; Sieberth, HG	1
Bunchman, TE; Gregory, MJ; Johnson, K; Kershaw, DB; Sedman, A; Smoyer, WE; Valentini, RP	1
Nakao, T; Ogura, M; Okada, T; Shimizu, T; Takahashi, H	1
Bakker, MA; Berden, JH; Desassis, JF; Raats, CJ; van den Born, J	1
Akiyama, K; Hayashi, Y; Kushiro, M; Makino, H; Matsuda, M; Ota, Z; Shikata, K; Shikata, Y; Sugimoto, H	1
Krämer, BK; Liebl, R; Riegger, GA; Schweda, F	1
Browne, R; Nolde-Hurlbert, B; Prashner, H; Seikaly, MG	1
Akashi, T; Hirano, T; Ihoya, N; Keira, T; Oka, K; Yoshida, M	1
Furuichi, K; Iwata, Y; Kobayashi, K; Sakai, N; Shimizu, M; Wada, T; Yokoyama, H; Yoshimoto, K	1
Anavi, BL; Dimitrakov, DJ; Kumchev, EP; Manev, EI; Nikolov, DG; Pandeva, SM; Tilkian, EE; Tzekov, VD; Tzvetkova, ZT	1
Choi, IJ; Jeong, HJ; Kim, JH; Kim, PK	1
Arisaka, O; Hoshi, M; Kano, K; Nishikura, K; Yamada, Y	1
Chew, ST; Chiang, GS; Vathsala, A; Woo, KT	1
Grabensee, B; Heering, P; Plum, J; Schneider, A	1
Dorywalski, T; Gorzkowska-Paczwa, M; Ksiazek, J; Tysarowska, A; Wieteska-Klimczak, A; Wyszyńska, T	1
Fujimi, S; Ikeda, K; Katafuchi, R; Nakayama, M; Tanaka, H; Yanase, T	1
Hamahira, K; Iijima, K; Kobayashi, A; Nakamura, H; Nozu, K; Tanaka, R; Yoshikawa, N	1
Fukatsu, A; Kita, T; Makibayashi, K	1
Kramer, P; Schalekamp, MA; Weimar, W; Wenting, GJ; Zietse, R	1
Weimar, W; Zietse, R	1
Arai, H; Kuroume, T; Maruyama, K; Seki, Y; Tomizawa, S	1
Guasch, A; Hall, BM; Myers, BD; Newton, L; Suranyi, M	1
Mendoza, SA; Tune, BM	1
Nyrop, M; Olgaard, K	1
Pomrantz, A; Suthanthiran, M; Tejani, A	1

Reviews

9 review(s) available for cyclosporine and Nephrosis, Lipoid

Article	Year
[Minimal change nephrotic syndrome]. Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:7 Topics: Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrosis, Lipoid; Prednisolone; Proteinuria; Pulse Therapy, Drug; Ribonucleosides	2010
The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:1 Topics: Adult; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrosis, Lipoid; Recurrence; Steroids; Treatment Outcome	2011
Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment. Minerva pediatrica, 2012, Volume: 64, Issue:2 Topics: Antibodies, Monoclonal, Murine-Derived; Child; Cyclosporine; Evidence-Based Medicine; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrosis, Lipoid; Podocytes; Randomized Controlled Trials as Topic; Rituximab; Tacrolimus; Treatment Outcome	2012
Treatment of nephrotic syndrome in children and controlled trials. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18 Suppl 6 Topics: Adrenal Cortex Hormones; Alkylating Agents; Child; Cyclosporine; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Nephrotic Syndrome; Randomized Controlled Trials as Topic	2003
Minimal change nephrotic syndrome after allogenic hematopoietic stem cell transplantation. Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:6 Topics: Adult; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Transplantation, Homologous; Treatment Outcome	2004
Cyclosporine in idiopathic nephrotic syndrome. Immunopharmacology and immunotoxicology, 1993, Volume: 15, Issue:4 Topics: Adult; Child; Creatinine; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria	1993
Pharmacologic management of adult idiopathic nephrotic syndrome. Clinical pharmacy, 1993, Volume: 12, Issue:6 Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclosporine; Drug Therapy, Combination; Edema; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria; Randomized Controlled Trials as Topic	1993
[Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults]. Nederlands tijdschrift voor geneeskunde, 1992, Sep-05, Volume: 136, Issue:36 Topics: Cyclosporine; Drug Administration Schedule; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Nephrosis, Lipoid; Nephrotic Syndrome	1992
Treatment of the nephrotic syndrome with cyclosporin A. Journal of autoimmunity, 1992, Volume: 5 Suppl A Topics: Chlorambucil; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone	1992

Trials

17 trial(s) available for cyclosporine and Nephrosis, Lipoid

Article	Year
Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial. Clinical and experimental nephrology, 2018, Volume: 22, Issue:2 Topics: Adult; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Nephrosis, Lipoid; Pilot Projects; Predictive Value of Tests; Prednisolone; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Young Adult	2018
Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2014, Volume: 29, Issue:12 Topics: Adolescent; Child; Child, Preschool; Cross-Over Studies; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrosis, Lipoid; Receptors, Urokinase Plasminogen Activator	2014
Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:11 Topics: Adolescent; Biopsy; Blood Pressure; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Gingival Hyperplasia; Glomerular Filtration Rate; Humans; Hypertrichosis; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrosis, Lipoid; Remission Induction; Secondary Prevention; Treatment Outcome	2008
Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome. Clinical and experimental nephrology, 2009, Volume: 13, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Cyclosporine; Emulsions; Humans; Immunosuppressive Agents; Intestinal Absorption; Middle Aged; Nephrosis, Lipoid; Postprandial Period; Young Adult	2009
Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:1 Topics: Adult; Cholesterol; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Prednisolone; Proteinuria; Recurrence; Remission Induction; Treatment Outcome	2010
Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2012, Volume: 27, Issue:4 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Kidney; Male; Nephrosis, Lipoid	2012
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatric nephrology (Berlin, Germany), 2013, Volume: 28, Issue:5 Topics: Adolescent; Child; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Prospective Studies; Recurrence; Remission Induction; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Young Adult	2013
Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome. Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:8 Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Japan; Methylprednisolone; Nephrosis, Lipoid; Prospective Studies; Pulse Therapy, Drug; Recurrence; Remission Induction; Treatment Outcome	2004
Lymphocyte drug sensitivity is useful for prediction of the antiproteinuric effect and relapse rate in cyclosporine treatment for frequent-relapse minimal change nephrotic syndrome. Kidney & blood pressure research, 2005, Volume: 28, Issue:4 Topics: Adolescent; Adult; Aged; Cell Division; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Lymphocytes; Male; Middle Aged; Nephrosis, Lipoid; Predictive Value of Tests; Proteinuria; Recurrence; Remission Induction; Sensitivity and Specificity	2005
The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea. Clinical nephrology, 1995, Volume: 43, Issue:6 Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Korea; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Prospective Studies; Recurrence; Treatment Outcome	1995
Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clinical nephrology, 1995, Volume: 44, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Cyclosporine; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Prospective Studies; Proteinuria; Remission Induction	1995
Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:4 Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Humans; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone	1996
Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome. Clinical pharmacology and therapeutics, 2000, Volume: 68, Issue:5 Topics: Adult; Cells, Cultured; Cyclosporine; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Interleukin-2; Leukocytes, Mononuclear; Male; Middle Aged; Mitosis; Nephrosis, Lipoid	2000
[Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2001, Volume: 11, Issue:62 Topics: Adolescent; Albuminuria; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Infant; Male; Nephrosis, Lipoid	2001
Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney international, 2002, Volume: 61, Issue:5 Topics: Biopsy; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Logistic Models; Male; Nephritis, Interstitial; Nephrosis, Lipoid; Proteinuria; Risk Factors	2002
Treatment of childhood nephrotic syndrome. Journal of the American Society of Nephrology : JASN, 1992, Volume: 3, Issue:4 Topics: Administration, Oral; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Child; Clinical Protocols; Cyclosporine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Humans; Incidence; Infusions, Intravenous; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Remission Induction	1992
A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron, 1991, Volume: 59, Issue:1 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Infant; Interleukin-2; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; T-Lymphocyte Subsets	1991

Other Studies

68 other study(ies) available for cyclosporine and Nephrosis, Lipoid

Article	Year
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis. Chinese medical journal, 2022, 04-05, Volume: 135, Issue:7 Topics: Adult; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Leflunomide; Nephrosis, Lipoid; Nephrotic Syndrome; Steroids	2022
Appropriate Timing of Kidney Biopsy to Detect Cyclosporine-Associated Nephrotoxicity in Idiopathic Nephrotic Syndrome in Children with C2 Monitoring. Indian journal of pediatrics, 2022, Volume: 89, Issue:10 Topics: Biopsy; Child; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Nephrosis, Lipoid; Nephrotic Syndrome	2022
[Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2022, Oct-21, Volume: 50, Issue:299 Topics: Adult; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Anticoagulants; Antiphospholipid Syndrome; Cyclophosphamide; Cyclosporine; Humans; Infant; Kidney; Kidney Diseases; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Rituximab; Young Adult	2022
Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists. Clinical and experimental nephrology, 2023, Volume: 27, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Cross-Sectional Studies; Cyclosporine; East Asian People; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Guideline Adherence; Humans; Internet; Nephrologists; Nephrosis, Lipoid; Nephrotic Syndrome; Practice Patterns, Physicians'; Surveys and Questionnaires	2023
Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine. Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:11 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Japan; Longitudinal Studies; Male; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult	2019
Effective improvement of minimal change nephrotic syndrome with uncontrollable high low-density lipoprotein cholesterol level using evolocumab accompanied by the development of acute pancreatitis. CEN case reports, 2020, Volume: 9, Issue:4 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Asian People; Cholesterol, LDL; Cyclosporine; Drug Therapy, Combination; Dyslipidemias; Female; Fluid Therapy; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Middle Aged; Nephrosis, Lipoid; Pancreatitis; PCSK9 Inhibitors; Proprotein Convertase 9; Remission Induction; Severity of Illness Index	2020
Efficacy of once-daily cyclosporine in Japanese children with steroid-dependent minimal change nephrotic syndrome. Clinical and experimental nephrology, 2021, Volume: 25, Issue:2 Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrosis, Lipoid; Retrospective Studies; Steroids; Time Factors; Treatment Outcome	2021
Chronic cyclosporine-induced nephrotoxicity in children with steroid-resistant nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2013, Volume: 28, Issue:10 Topics: Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Male; Nephrosis, Lipoid; Nephrotic Syndrome	2013
Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults. Clinical and experimental nephrology, 2015, Volume: 19, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Length of Stay; Male; Methylprednisolone; Middle Aged; Nephrosis, Lipoid; Recurrence; Retrospective Studies; Severity of Illness Index; Young Adult	2015
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR). Clinical and experimental nephrology, 2015, Volume: 19, Issue:3 Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome	2015
Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatric nephrology (Berlin, Germany), 2015, Volume: 30, Issue:9 Topics: Actinin; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Germany; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Intracellular Signaling Peptides and Proteins; Kidney; Male; Medication Therapy Management; Membrane Proteins; Nephrosis, Lipoid; Pharmacogenetics; Remission Induction; Retrospective Studies; Secondary Prevention	2015
Two children with steroid-responsive nephrotic syndrome complicated by cerebral venous sinus thrombosis. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2015, Volume: 35, Issue:5 Topics: Adult; Anticoagulants; Child, Preschool; Cyclosporine; Early Diagnosis; Heparin; Heparin, Low-Molecular-Weight; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Nephrosis, Lipoid; Neuroimaging; Prednisone; Remission Induction; Sinus Thrombosis, Intracranial; Thrombophilia	2015
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children. Pediatric nephrology (Berlin, Germany), 2016, Volume: 31, Issue:3 Topics: Adolescent; Cell Proliferation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Infant; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome	2016
Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Scientific reports, 2016, 09-01, Volume: 6 Topics: Animals; Apoptosis; Calcineurin Inhibitors; Cell Line; Cyclosporine; Male; MAP Kinase Signaling System; Mice; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats, Sprague-Dawley; Tacrolimus	2016
Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease. Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:3 Topics: Adolescent; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Proteinuria; Remission Induction; Tacrolimus; Treatment Outcome; Young Adult	2017
Clinicopathologic correlation and outcome of C1q nephropathy. Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:6 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Complement C1q; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Recurrence; Time Factors; Treatment Outcome; Young Adult	2008
[Combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: comparison with prednisolone therapy]. Nihon Jinzo Gakkai shi, 2008, Volume: 50, Issue:5 Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Length of Stay; Male; Middle Aged; Nephrosis, Lipoid; Prednisolone; Quality of Life; Retrospective Studies; Treatment Outcome	2008
Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:6 Topics: Biopsy; Chemotherapy, Adjuvant; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Fluorescent Antibody Technique; Glomerular Mesangium; Humans; Immunoglobulin M; Immunosuppressive Agents; Kidney; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Retrospective Studies; Secondary Prevention; Treatment Outcome	2009
Remission of refractory minimal change nephrotic syndrome after basiliximab therapy. Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:7 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Basiliximab; Child, Preschool; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephrosis, Lipoid; Recombinant Fusion Proteins; Ribonucleosides	2009
[Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma]. Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:2 Topics: Aged; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Neoplasm Recurrence, Local; Nephrosis, Lipoid; Prednisolone; Thymoma; Thymus Neoplasms; Treatment Outcome; Vascular Endothelial Growth Factor A	2009
Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children. Iranian journal of kidney diseases, 2009, Volume: 3, Issue:3 Topics: Antifungal Agents; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Ketoconazole; Male; Nephrosis, Lipoid; Remission Induction; Retrospective Studies; Secondary Prevention; Steroids	2009
Management of childhood onset nephrotic syndrome. Pediatrics, 2009, Volume: 124, Issue:2 Topics: Antineoplastic Agents; Biopsy; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone	2009
Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:3 Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Lymphocytes; Male; Nephrosis, Lipoid; Prednisolone; Recurrence; Rituximab; Steroids; Treatment Outcome	2010
Acute kidney injury in a child with MCNS during cyclosporine A and acyclovir treatment. Clinical and experimental nephrology, 2010, Volume: 14, Issue:6 Topics: Acute Kidney Injury; Acyclovir; Chickenpox; Child, Preschool; Cyclosporine; Female; Humans; Nephrosis, Lipoid	2010
Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome. Journal of clinical pathology, 2011, Volume: 64, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Kidney Diseases; Male; Nephrosis, Lipoid; Risk Factors	2011
Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome. Clinical and experimental nephrology, 2011, Volume: 15, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Prednisolone; Recurrence; Remission Induction; Rituximab; Time Factors; Treatment Outcome	2011
Transition of severe diffuse mesangial hypercellularity to minimal change disease in a child with steroid-resistant nephrotic syndrome. Clinical nephrology, 2011, Volume: 76, Issue:6 Topics: Adrenal Cortex Hormones; Cyclosporine; Drug Resistance; Glomerular Mesangium; Humans; Infant; Male; Nephrosis, Lipoid; Nephrotic Syndrome	2011
GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E. Clinical nephrology, 2012, Volume: 77, Issue:4 Topics: Adolescent; Biomarkers; Biopsy; Child; Comparative Genomic Hybridization; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Glutathione Transferase; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Mutation; Nephrosis, Lipoid; Polymerase Chain Reaction; Proteinuria; Reactive Oxygen Species; Ribonucleosides; T-Lymphocytes, Helper-Inducer; Treatment Outcome	2012
Patients with adult minimal change nephrotic syndrome treated with long-term cyclosporine did not experience a reduction in their eGFR. Clinical nephrology, 2013, Volume: 79, Issue:2 Topics: Adult; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Secondary Prevention	2013
[Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults]. Nihon Jinzo Gakkai shi, 2002, Volume: 44, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Prednisone	2002
[Minimal Change Glomerulonephritis]. Der Internist, 2003, Volume: 44, Issue:9 Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Nephrosis, Lipoid; Steroids; Tacrolimus; Treatment Outcome	2003
Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 42, Issue:5 Topics: Anti-Inflammatory Agents; Cyclophosphamide; Cyclosporine; Drug Eruptions; Drug Resistance; Female; Flushing; Humans; Immunosuppressive Agents; Middle Aged; Nephrosis, Lipoid; Prednisolone; Remission Induction; Steroids; Tacrolimus	2003
Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome. Clinical pharmacology and therapeutics, 2003, Volume: 74, Issue:6 Topics: Adult; Analysis of Variance; Case-Control Studies; Cholesterol; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid	2003
Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity. Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:3 Topics: Biomarkers; Biopsy; Capillaries; Child; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Glomerulus; Macrophages; Nephrosis, Lipoid; Osteopontin; Sialoglycoproteins; Transforming Growth Factor beta	2004
Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:11 Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Pulse Therapy, Drug; Treatment Failure; Treatment Outcome	2004
Nephrotic syndrome after stem cell transplantation. Clinical transplantation, 2005, Volume: 19, Issue:1 Topics: Adult; Cyclosporine; Fatal Outcome; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Stem Cell Transplantation; Treatment Outcome	2005
Co-administration of cyclosporine and ketoconazole in children with minimal change nephrotic syndrome. Nephron. Clinical practice, 2005, Volume: 100, Issue:2 Topics: Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Nephrosis, Lipoid; Retrospective Studies	2005
High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity. Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:12 Topics: Adolescent; Adult; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Ribonucleosides; Secondary Prevention; Time Factors; Treatment Outcome	2005
Granulomatous interstitial nephritis treated with a tumour necrosis factor-alpha inhibitor. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8 Topics: Antibodies, Monoclonal; Child, Preschool; Cyclosporine; Diagnostic Errors; Dwarfism; Granuloma; Hematuria; Humans; Immunosuppressive Agents; Infliximab; Male; Nephritis, Interstitial; Nephrosis, Lipoid; Nephrotic Syndrome; Obesity; Prednisolone; Proteinuria; Puberty, Delayed; Recurrence; Remission Induction; Tacrolimus; Tumor Necrosis Factor-alpha	2006
Spontaneous remission of therapy-resistant minimal change nephritis in an adult woman 12 years after onset of the disease. Wiener medizinische Wochenschrift (1946), 2006, Volume: 156, Issue:13-14 Topics: Adult; Biopsy; Combined Modality Therapy; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Edema; Female; Follow-Up Studies; Furosemide; Glomerular Basement Membrane; Hemodiafiltration; Humans; Immunosuppressive Agents; Kidney Glomerulus; Nephrosis, Lipoid; Prednisolone; Remission, Spontaneous; Retreatment	2006
[Advances in the treatment of adult nephrotic syndrome]. Nihon Jinzo Gakkai shi, 2007, Volume: 49, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Rituximab; Tacrolimus	2007
Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clinical journal of the American Society of Nephrology : CJASN, 2007, Volume: 2, Issue:3 Topics: Acute Kidney Injury; Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Nephrosis, Lipoid; Recurrence; Retrospective Studies; Steroids; Treatment Outcome	2007
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney international, 2007, Volume: 72, Issue:12 Topics: Cyclosporine; Education; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Nephrotic Syndrome; Practice Guidelines as Topic	2007
Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007, Volume: 50, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclosporine; Glomerular Filtration Rate; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Glomerulus; Male; Nephrosis, Lipoid; Permeability; Remission Induction	2007
Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years. Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:4 Topics: Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Nephrosis, Lipoid	2008
FK 506 for vascular permeability factor production in minimal change nephrotic syndrome. Nephron, 1994, Volume: 66, Issue:4 Topics: Child; Child, Preschool; Cyclosporine; Endothelial Growth Factors; Female; Humans; In Vitro Techniques; Lymphokines; Male; Nephrosis, Lipoid; T-Lymphocytes; Tacrolimus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1994
Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood. Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:4 Topics: Adolescent; Child; Creatinine; Cyclosporine; Female; Humans; Longitudinal Studies; Male; Nephrosis, Lipoid; Prednisolone; Recurrence	1994
Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 1994, Volume: 8, Issue:4 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Glomerular Filtration Rate; Humans; Kidney; Nephrosis, Lipoid	1994
Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis. Clinical nephrology, 1994, Volume: 42, Issue:3 Topics: Biopsy; Child; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Male; Nephrosis, Lipoid; Retrospective Studies; Time Factors	1994
Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie. Kidney international, 1994, Volume: 45, Issue:5 Topics: Adolescent; Adult; Creatinine; Cyclosporine; Drug Evaluation; Drug Tolerance; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Nephrosis, Lipoid	1994
Mesangial IgG in childhood minimal change disease: clinical relevance. Clinical nephrology, 1993, Volume: 39, Issue:5 Topics: Biopsy; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Fluorescent Antibody Technique; Follow-Up Studies; Glomerular Mesangium; Humans; Immunoglobulin G; Infant; Nephrosis, Lipoid; Prednisone; Prognosis; Retrospective Studies	1993
[Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment]. Nihon Jinzo Gakkai shi, 1996, Volume: 38, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Blood Component Removal; Combined Modality Therapy; Cyclosporine; Drug Resistance; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins, LDL; Male; Nephrosis, Lipoid; Prednisolone; Remission Induction	1996
Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats. Nephron, 1997, Volume: 75, Issue:3 Topics: Albuminuria; Animals; Cyclosporine; Doxorubicin; Glomerular Filtration Rate; Lysine; Male; Nephrosis, Lipoid; Olive Oil; Plant Oils; Proteinuria; Rats; Rats, Wistar; Serum Albumin	1997
A case of early-stage diabetic nephropathy complicated by minimal change nephrotic syndrome treated with cyclosporin A. Nephron, 1997, Volume: 75, Issue:4 Topics: Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nephrosis, Lipoid	1997
Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:11 Topics: Adrenal Cortex Hormones; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Tacrolimus	1997
Long-term clinical and pathological effects of cyclosporin in children with nephrosis. Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:3 Topics: Atrophy; Child; Child, Preschool; Cyclosporine; Fibrosis; Humans; Infant; Kidney; Kidney Tubules; Nephrosis, Lipoid; Retrospective Studies; Time Factors	2000
[A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy]. Nihon Jinzo Gakkai shi, 2000, Volume: 42, Issue:8 Topics: Administration, Oral; Aged; Cyclosporine; Female; Humans; Methylprednisolone; Nephrosis, Lipoid; Prednisolone; Pulse Therapy, Drug; Recurrence; Remission Induction; Time Factors; Treatment Outcome	2000
Cyclosporin A in the treatment of patients with nephrotic syndrome. Folia medica, 2000, Volume: 42, Issue:2 Topics: Adult; Amyloidosis; Cyclosporine; Female; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome	2000
Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome. Clinical nephrology, 2001, Volume: 55, Issue:4 Topics: Child; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Hypertrophy; Immunosuppressive Agents; Kidney Glomerulus; Kidney Tubules; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone	2001
Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy. Clinical nephrology, 2001, Volume: 55, Issue:5 Topics: Adolescent; Child; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Recurrence	2001
Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome. Annals of the Academy of Medicine, Singapore, 2001, Volume: 30, Issue:4 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid	2001
[Effect of cyclosporin A on renal function in patients with glomerulonephritis]. Deutsche medizinische Wochenschrift (1946), 2001, Oct-05, Volume: 126, Issue:40 Topics: Adult; Blood Pressure; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Kidney Function Tests; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Prospective Studies	2001
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 39, Issue:3 Topics: Adult; Age of Onset; Aged; Blood Urea Nitrogen; Creatinine; Cyclophosphamide; Cyclosporine; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Prednisolone; Proteinuria; Recurrence; Remission Induction; Retrospective Studies; Time Factors	2002
[Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin]. Nihon Jinzo Gakkai shi, 2002, Volume: 44, Issue:2 Topics: Anticholesteremic Agents; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Emulsions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hyperlipidemias; Immunosuppressive Agents; Indoles; Male; Middle Aged; Nephrosis, Lipoid; Remission Induction; Treatment Outcome	2002
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clinical science (London, England : 1979), 1992, Volume: 82, Issue:6 Topics: Adult; Aged; Basement Membrane; Cell Membrane Permeability; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Glomerulus; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria	1992
Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome. Nephron, 1992, Volume: 62, Issue:1 Topics: Animals; Cells, Cultured; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Endothelial Growth Factors; Female; Guinea Pigs; Humans; Lymphokines; Male; Nephrosis, Lipoid; Skin; T-Lymphocytes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1992
Short-term responsiveness of membranous glomerulopathy to cyclosporine. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1992, Volume: 20, Issue:5 Topics: Adult; Aged; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Hypertension; Interferon-alpha; Interleukin-1; Interleukin-2; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Nephrosis, Lipoid; Proteinuria; Recurrence; Remission Induction; T-Lymphocyte Subsets; Treatment Outcome; Tumor Necrosis Factor-alpha	1992
[Cyclosporin A treatment of adult patients with severe nephrotic syndrome]. Ugeskrift for laeger, 1992, Jul-06, Volume: 154, Issue:28 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Prognosis	1992